DEX-24740-55923
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 900 / CA
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-13
Registered in v-safe
-
2021-08-13
Dose 1 — Pfizer-BioNTech
- 2021-08-13
- 2021-08-14
-
2021-08-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-20
-
2021-08-27
Survey response — day 14, dose 1MedDRA: Palpitations, Swelling — Feeling: FairFree text: Heart palpitations, swellingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-03
Dose 2 — Pfizer-BioNTech
- 2021-09-03
-
2021-09-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-09-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-09
- 2021-09-10
- 2021-09-19
- 2021-09-26
- 2021-10-03
- 2021-10-08
- 2021-10-15
- 2021-12-03
- 2022-03-06
-
2022-09-03
Survey response — 12 months, dose 2MedDRA: Cholecystitis, Mediastinal mass, Thrombosis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Cholecystectistis, blood clots, and yet to diagnosed mediastinal mass.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-09-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
| 2 | 2021-09-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 14, dose 1
Symptoms: Heart palpitations, swelling
Release 12 — 12 months, dose 2
Symptoms: Cholecystectistis, blood clots, and yet to diagnosed mediastinal mass.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholecystitis | · | · | ✓ |
| SD | Mediastinal mass | · | · | ✓ |
| SD | Palpitations | ✓ | · | ✓ |
| SD | Swelling | ✓ | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release